中药治疗免疫检查点抑制剂相关性结肠炎的作用机制研究进展
CSTR:
作者:
作者单位:

(1.陕西中医药大学中西医结合学院中西医临床医学系,陕西 咸阳 712046;2.陕西中医药大学继续教育学院,陕西 咸阳712046;3.陕西中医药大学附属医院普外科,陕西 咸阳712000)

作者简介:

通讯作者:

中图分类号:

基金项目:

陕西中医药大学附属医院科研课题(2020ZJ003)


Research progress on underlying mechanism of traditional Chinese medicine in treatment of immune checkpoint inhibitor-induced colitis
Author:
Affiliation:

(1.Faculty of Clinical Medicine of Integrated Chinese and Western Medicine, College of Integrated Chinese and Western Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China;2.College of Continuing Education, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China;3.Department of General Surgery, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China)

Fund Project:

This work was supported by the Scientific Research Project of Affliated Hospital of Shaanxi University of Chinese Medicine(202oZJoO3).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    肿瘤免疫疗法的出现极大地改变了许多晚期恶性肿瘤的治疗格局。然而,随着免疫检查点抑制剂(ICI)的广泛应用,其所引发的一系列免疫相关不良事件(irAEs)日益凸显,其中ICI相关性结肠炎是最常见的胃肠道irAEs之一,严重时可导致治疗中断甚至患者死亡。目前,西医主要采用糖皮质激素及生物制剂进行治疗,但存在疗效不均、副作用及复发风险等问题。近年来,中药在治疗ICI相关性结肠炎方面显示出多靶点、整体调节的独特优势。本文通过综述国内外相关文献,从调节调节性T细胞/辅助性T细胞17平衡、调控巨噬细胞极化、恢复辅助性T细胞1/辅助性T细胞2平衡及改善肠道菌群等方面,系统阐述了中药及其活性成分治疗ICI相关性结肠炎的潜在作用机制,以期为减轻肿瘤irAEs、提高患者生活质量提供新的思路与参考。

    Abstract:

    Tumor immunotherapy has profoundly transformed the therapeutic landscape for many advanced malignancies. However, with the increasing clinical application of immune checkpoint inhibitors (ICI), a spectrum of immune-related adverse events (irAEs) has emerged, among which ICI-induced colitis is one of the most common gastrointestinal irAEs. In severe cases, it can lead to treatment interruption and even patient death. The current mainstay treatments, glucocorticoids and biological agents, are often associated with inconsistent efficacy, significant side effects, and a risk of recurrence. In recent years, traditional Chinese medicine (TCM) has demonstrated unique advantages in treating ICI-induced colitis through its multi-target and holistic regulatory approach. In this article, based on advanced domestic and international literature, we systematically elaborated the potential mechanisms of traditional Chinese medicine and its active components in treatment of ICI-induced colitis, from the aspects of regulating regulatory T cell/T helper 17 cell balance, modulating macrophage polarization, restoring T helper 1 cell/T helper 2 cell balance, and improving gut microbiota, aiming to provide new ideas and references for alleviating irAEs and improving patient′s quality of life.

    参考文献
    相似文献
    引证文献
引用本文

张婵婵,孙建飞,肖刚,郭辉,任航.中药治疗免疫检查点抑制剂相关性结肠炎的作用机制研究进展[J].中华老年多器官疾病杂志,2026,25(2):157-160
DOI:10.11915/j. issn.1671-5403.2026.02.034

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-05-19
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-02-03
  • 出版日期:
文章二维码